Department of Otolaryngology - Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Br J Surg. 2017 Oct;104(11):1523-1531. doi: 10.1002/bjs.10582. Epub 2017 Jul 14.
Intraoperative nerve monitoring (IONM) provides dynamic neural information and is recommended for high-risk thyroid surgery. In this analysis, the cost-effectiveness of IONM in preventing bilateral recurrent laryngeal nerve (RLN) injury was investigated.
A Markov chain model was constructed based on IONM use. The base-case patient was defined as a 40-year-old woman presenting with a 4·1-cm left-sided papillary thyroid cancer who developed RLN injury with loss of monitoring signal during planned bilateral thyroidectomy. It was hypothesized that, if the surgeon had used IONM, the RLN injury would have been detected and the operation would have been concluded as a thyroid lobectomy to avoid the risk of contralateral RLN injury. Cost in US dollars was converted to euros; probabilities and utility scores were identified from the literature and government resources. Length of follow-up was set as 20 years, and willingness-to-pay (WTP) as €38 000 (US $50 000) per quality-adjusted life-year (QALY).
At the end of year 20, the not using IONM strategy accrued €163 995·40 (US $215 783·43) and an effectiveness of 14·15 QALYs, whereas use of the IONM strategy accrued €170 283·68 (US $224 057·48) and an effectiveness of 14·33 QALYs. The incremental cost-effectiveness ratio, comparing use versus no use of IONM, was €35 285·26 (US $46 427·97) per QALY, which is below the proposed WTP, indicating that IONM is the preferred and cost-effective management plan. A Monte Carlo simulation test that considered variability of the main study factors in a hypothetical sample of 10 000 patients showed IONM to be the preferred strategy in 85·8 per cent of the population.
Use of IONM is cost-effective in patients undergoing bilateral thyroid surgery.
术中神经监测(IONM)提供动态神经信息,建议用于高危甲状腺手术。在此分析中,研究了 IONM 预防双侧喉返神经(RLN)损伤的成本效益。
基于 IONM 的使用构建了一个马尔可夫链模型。基础病例患者定义为 40 岁女性,患有 4.1 厘米左侧甲状腺乳头状癌,在计划双侧甲状腺切除术期间出现 RLN 损伤和监测信号丢失。假设如果外科医生使用了 IONM,则可以检测到 RLN 损伤,并将手术结束为甲状腺叶切除术,以避免对侧 RLN 损伤的风险。以美元计价的成本转换为欧元;概率和效用评分来自文献和政府资源。随访时间设定为 20 年,意愿支付(WTP)为每质量调整生命年(QALY)38000 欧元(50000 美元)。
在第 20 年末,不使用 IONM 策略累积了 163995.40 欧元(215783.43 美元)和 14.15 个 QALYs,而使用 IONM 策略累积了 170283.68 欧元(224057.48 美元)和 14.33 个 QALYs。比较使用与不使用 IONM 的增量成本效益比为 35285.26 欧元(46427.97 美元)/QALY,低于提议的 WTP,表明 IONM 是首选且具有成本效益的管理方案。一项考虑主要研究因素在 10000 名患者的假设样本中的变异性的蒙特卡罗模拟测试表明,IONM 在 85.8%的人群中是首选策略。
在双侧甲状腺手术患者中,使用 IONM 具有成本效益。